Document is current
Any future updates will be listed below
-
Authors
AbdulJabbar, Khalid
Castillo, Simon P. http://orcid.org/0000-0002-0606-2160
Hughes, Katherine http://orcid.org/0000-0002-3331-1249
Davidson, Hannah
Boddy, Amy M. http://orcid.org/0000-0002-7990-2415
Abegglen, Lisa M. http://orcid.org/0000-0003-3607-3001
Minoli, Lucia
Iussich, Selina
Murchison, Elizabeth P. http://orcid.org/0000-0001-7462-8907
Graham, Trevor A. http://orcid.org/0000-0001-9582-1597
Spiro, Simon
Maley, Carlo C. http://orcid.org/0000-0002-0745-7076
Aresu, Luca http://orcid.org/0000-0002-7893-1740
Palmieri, Chiara
Yuan, Yinyin http://orcid.org/0000-0002-8556-4707
- License Information
-
More Information
Article History
Received: 21 March 2022
Accepted: 4 April 2023
First Online: 26 April 2023
Competing interests
: The funders had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. Y.Y. has received speakers bureau honoraria from Roche and consulted for Merck and Co Inc. L.M.A. is a share-holder and consultant to PEEL Therapeutics, Inc. The remaining authors declare no competing interests.
